1. Presence and Future Under the Clinical Trials DirectiveDr. med. Ingrid Klingmann, FFPM, FBCPM Pharmaplex bvbaBrussels 2. Clinical Trials DirectiveNumbers of Clinical Trials…

Slide 1SARQA/DKG Conference 3-4 October 2002 1 SARQA/DKG Conference 3-4 OCTOBER 2002 Annex 13 Update An Industry Perspective Michael J Cooke Director, Global GMP QA AstraZeneca…

Slide 1FDA\ CDER\OPASS\OB ASA-Industry Workshop,Sept.17- 19,2000 Bethesda, MD Multi-Clinic and Multi-National Trials: A regulatory perspective Charles Anello Sc.D. Deputy…

1. IND Process andIND Process and Global Clinical Trials in KoreaGlobal Clinical Trials in Korea In-Sook Park, Ph.D Drug Evaluation Department Korea Food and Drug Administration…

1. White Paper The EU Clinical Trials Regulation – Main Changes and Challenges 2. The EU Clinical Trials Regulation – Main Changes and Challenges February 2015 Page |…

Slide 1The ICH E5 Guidance: An Update on Experiences with its Implementation The ICH E5 Guidance: An Update on Experiences with its Implementation Robert T. O’Neill, Ph.D.…

Vienna Life Sciences explore China (Part1) LIFE SCIENCE AUSTRIA VIENNA â¹ LISAviennaâs newsletter 01/2012 âSurprisingly Ingeniousâ was the slogan when Vienna biotech…